Clinical Trials Browser

OTHER × Body Weight × Metformin × Clear all

NCT01482286 2022-03-15

PULSE

Phase 3 Terminated

32 enrolled 10 charts

Body Weight, Insulin Resistance, Motor Activity, Polycystic Ovary Syndrome

NCT02941445 2016-10-21

Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss

Phase 4 Completed

Body Weight, Polycystic Ovary Syndrome